Canada Life’s Altimmune ALT Stock Holding History

Canada Life’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,354	Closed	-$22K	–	1944
2025 Q1	$22K	Hold	4,354	–	–	﹤0.01%	1923
2024 Q4	$31K	Hold	4,354	–	–	﹤0.01%	1923
2024 Q3	$27K	Hold	4,354	–	–	﹤0.01%	1994
2024 Q2	$29K	Hold	4,354	–	–	﹤0.01%	2003
2024 Q1	$44K	Buy	+4,354	New	+$44.3K	﹤0.01%	2030
2023 Q2	–	Sell	-2,465	Closed	-$10K	–	2260
2023 Q1	$10K	Hold	2,465	–	–	﹤0.01%	2294
2022 Q4	$41K	Buy	+2,465	New	+$27.7K	﹤0.01%	2109

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Life's ALT Position: Q2 2025 in Review

Canada Life sold out of Altimmune (ALT) in Q2 2025, closing a stake of 4,354 shares — an estimated $22K sold.

Canada Life first reported a position in ALT in Q4 2022 and held it in 7 quarters. The position peaked at $44K in Q1 2024. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

Canada Life reported no remaining Altimmune position as of Q2 2025 after selling out during the quarter.
Canada Life sold 4,354 Altimmune shares in Q2 2025, an estimated $22K.
Canada Life first reported a position in Altimmune in Q4 2022 and held it in 7 quarters.
Canada Life's Altimmune position peaked at $44K in Q1 2024.
180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on Canada Life's 13F filing for Q2 2025, filed 15 Aug 2025.